Cargando…
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Na(v)1.4
Sodium channel myotonia is a form of muscle channelopathy due to mutations that affect the Na(v)1.4 channel. We describe seven families with a series of symptoms ranging from asymptomatic to clearly myotonic signs that have in common two novel mutations, p.Ile215Thr and p.Gly241Val, in the first dom...
Autores principales: | Pagliarani, Serena, Lucchiari, Sabrina, Scarlato, Marina, Redaelli, Elisa, Modoni, Anna, Magri, Francesca, Fossati, Barbara, Previtali, Stefano C., Sansone, Valeria A., Lecchi, Marzia, Lo Monaco, Mauro, Meola, Giovanni, Comi, Giacomo P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201054/ https://www.ncbi.nlm.nih.gov/pubmed/32411069 http://dx.doi.org/10.3389/fneur.2020.00255 |
Ejemplares similares
-
Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation
por: Desaphy, Jean-François, et al.
Publicado: (2016) -
Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis
por: Pagliarani, Serena, et al.
Publicado: (2022) -
Isolated eyelid closure myotonia in two families with sodium channel myotonia
por: Stunnenberg, B. C., et al.
Publicado: (2009) -
Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy
por: Desaphy, Jean-François, et al.
Publicado: (2012) -
Long-Term Safety and Usefulness of Mexiletine in a Large Cohort of Patients Affected by Non-dystrophic Myotonias
por: Modoni, Anna, et al.
Publicado: (2020)